Recent content by torpedoswap

I buy on weakness and sell on the ups constantly to reduce risk & get my price basis down while booking small profits. I also feel the same way. The 3rd drug will get a green light in November getting it to 2/3 and ide-cell will most likely go beyond the March deadline. I will still hold on to...

They have been taking it down in a rush for the last week or so. From $3.60 or so down below $3, so 20% in a week. I entered sooner than I should have, but I am adding and averaging down.

Okay, maybe I needed to research a bit deeper. So the ide-cell refile from July is the weakest link of the 3 at this point due to the FDA timeline dependency. A normal processing time of 10 months would put it beyond the deadline (counting from July 31st) but a fast track review (which it is...

After the spike from the CAR-T refiling, it was trading flat for a while but last week they took it down almost 20% ..... this could be in the anticipation of an FDA approval. I know this is binary and risky but I don't believe this is a dud & that BMY can get away with intentionally delaying...

Interesting price action, I added to my position and will add a bit more if it drops further. Not sure how long FDA needs to turn around the application but it has to be sometime this month.

I had also been patiently waiting but without position. I knew they were going to refile, so got back in just 2 days before this spike. I think it will get closer to $5 once FDA accepts it.

After trading sideways for a couple of months, looks like we finally have some action. BMS just refiled the application. https://pharmaphorum.com/news/bms-2/

I am hesitating to go heavy on this. If all goes well ide-cel by July & liso-cel by Nov should get us home, with a 4 month buffer until March 2021, but what worries me is CV might be an excuse for delay from both FDA & BMY. Fingers crossed.

This is an all or nothing deal, so any positive news will drive price up but the moment there is a hint of failure, it will be worthless. I was checking the chart yesterday & I almost did not notice they drove price down to $1.60 pre-market the day it fell last week. Normally I incline more on...

Low volume (so far 700K vs 30M+ yesterday), so I doubt if there will be another bloodbath ..... should hover around this level for a few days and stabilize. I will add a bit today. What are you thoughts on the delay & resubmission possibly in July? I feel this time we will see $4 only once FDA...

It will go back up, can’t win them all. My portfolio is so red that a 60% profit was tempting, so I sold & got lucky. Today I bought very few, the rejection gives a 2-3 month setback before they resubmit & CV may slow things. I am curious to see the price action tomorrow, hopefully doesn’t...

I just got back in .... although the FDA rejection does hurt the success probability. Not sure if it dipped below 2 pre-market but if it does again, I will double down. I am less confident on this than before though. Lets see how things work out, fingers crossed!

I almost forgot it went below $2 last time ..... will buy only once it is below $3 this time

Going down on high volume, what happened? Liso-cell submission extension by FDA affecting this? I think I will get back in half position if it dips below $3.5 today & add more if they push it below $3 later. I don't think much has changed fundamentally.

It is going up on low volume and until $5 it makes sense fundamentally, so I think you are doing good. Its up 60 cents from the point I sold .... oh good old hind sight! :)